Keyphrases
Ablative Therapy
20%
Area under the Receiver Operating Characteristic Curve
20%
Barrett's Esophagus
40%
Confidence Interval
100%
Endoscopy
20%
Esophageal Adenocarcinoma
40%
High-grade Dysplasia
20%
Histologic Progression
100%
Internal Validation
20%
Logistic Regression
20%
Long-segment Barrett's Esophagus
20%
Low Dose Rate
20%
Low-grade Dysplasia
40%
Model Validation
20%
Neutrophil-to-lymphocyte Ratio
20%
Nondysplastic Barrett's Esophagus
100%
Odds Ratio
100%
Patient Selection
20%
Prediction Model
100%
Progression Rate
20%
Referral Center
20%
Renal Failure
20%
Risk of Progression
20%
Surveillance Program
20%
Training Population
20%
Validation Cohort
20%
Nursing and Health Professions
Ablation Therapy
20%
Barrett Esophagus
100%
Confidence Interval
100%
Dysplasia
60%
Endoscopy
20%
Esophageal Adenocarcinoma
40%
Kidney Failure
20%
Logistic Regression Analysis
20%
Neutrophil Lymphocyte Ratio
20%
Odds Ratio
100%
Patient Referral
20%
Patient Selection
20%
Receiver Operating Characteristic
20%
Medicine and Dentistry
Ablation Therapy
20%
Barrett Esophagus
100%
Dysplasia
60%
Endoscopy
20%
Esophageal Adenocarcinoma
40%
Logistic Regression Analysis
20%
Lymphocyte
20%
Neutrophil
20%
Odds Ratio
100%
Patient Referral
20%
Patient Selection
20%
Renal Failure
20%